dentatorubral-pallidoluysian atrophy

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation	Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, dentatorubral-pallidoluysian atrophy, epilepsy, nervous system disorder, progressive myoclonus epilepsy	Active, not recruiting	Phase 1 / Phase 2	2026-07-13	NCT07084311
Personalized Antisense Oligonucleotide Therapy for A Single Participant With ATN1 Gene Mutation	Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, dentatorubral-pallidoluysian atrophy, epilepsy, nervous system disorder, progressive myoclonus epilepsy	Active, not recruiting	Phase 1 / Phase 2	2026-04-09	NCT06706388
Personalized Antisense Oligonucleotide for A Single Participant (nL62541) With ATN1 Gene Mutation	Epilepsies, Myoclonic, Epilepsy, Generalized, Epileptic Syndromes, brain disorder, central nervous system disorder, dentatorubral-pallidoluysian atrophy, epilepsy, nervous system disorder, progressive myoclonus epilepsy	Active, not recruiting	Phase 1 / Phase 2	2026-04-07	NCT07221760
CureDRPLA Global Patient Registry	dentatorubral-pallidoluysian atrophy	Recruiting	Not stated	2026-03-17	NCT05489393

Clinical trials